Prof. Dr. med. Oliver Schnell

Lehrstuhl für Neurochirurgie

A randomised, open label phase III trial with nimotuzumab, an anti-epidermal growth factor receptor monoclonal antibody in the treatment of newly diagnosed adult glioblastoma (2015) Westphal M, Heese O, Steinbach JP, Schnell O, Schackert G, Mehdorn M, Schulz D, et al. Journal article Hippocampal EUD in primarily irradiated glioblastoma patients (2014) Bodensohn R, Söhn M, Ganswindt U, Schupp G, Nachbichler SB, Schnell O, Belka C, Niyazi M Journal article Cilengitide combined with standard treatment for patients with newly diagnosed glioblastoma with methylated MGMT promoter (CENTRIC EORTC 26071-22072 study): a multicentre, randomised, open-label, phase 3 trial (2014) Stupp R, Hegi ME, Gorlia T, Erridge SC, Perry J, Hong YK, Aldape KD, et al. Journal article Dynamic 18F-FET PET in newly diagnosed astrocytic low-grade glioma identifies high-risk patients (2014) Jansen NL, Suchorska B, Wenter V, Eigenbrod S, Schmid-Tannwald C, Zwergal A, Niyazi M, et al. Journal article 5-ALA based photodynamic management of glioblastoma (2014) Rühm A, Stepp H, Beyer W, Hennig G, Pongratz T, Sroka R, Schnell O, et al. Conference contribution A comprehensive analysis of vascular complications in 3,889 glioma patients from the German Glioma Network (2013) Seidel C, Hentschel B, Simon M, Schnell O, Heese O, Tatagiba M, Krex D, et al. Journal article End-of-life caregivers' perception of medical and psychological support during the final weeks of glioma patients: A questionnaire-based survey (2013) Heese O, Vogeler E, Martens T, Schnell O, Tonn JC, Simon M, Schramm J, et al. Journal article Predictive impact of MGMT promoter methylation in glioblastoma of the elderly (2012) Reifenberger G, Hentschel B, Felsberg J, Schackert G, Simon M, Schnell O, Westphal M, et al. Journal article New similarity search based glioma grading (2012) Haegler K, Wiesmann M, Boehm C, Freiherr J, Schnell O, Brueckmann H, Tonn JC, Linn J Journal article Krüppel-like factor 8 (KLF8) is expressed in gliomas of different WHO grades and is essential for tumor cell proliferation (2012) Schnell O, Romagna A, Jaehnert I, Albrecht V, Eigenbrod S, Juerchott K, Kretzschmar H, et al. Journal article